New flu drug Baloxavirmarboxil extremely effective: Roche shares after a positive study in high-altitude flight

The Roche share is finally rising again. Recently, the securities of the pharmaceutical company have cracked the mark of 230 Swiss francs. The recently published positive study of the novel flu drug Baloxavirmarboxil is just one of many good news that the group has been able to announce in recent days.